Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
IRTC iRhythm Technologies	$158.52 +0.4%	$146.64	$55.92 ▼ $168.32	$5.07B	1.41	544,015 shs	305,014 shs
ISRG Intuitive Surgical	$479.20 -0.4%	$506.84	$425.00 ▼ $616.00	$172.53B	1.59	2.17 million shs	1.88 million shs
PATH UiPath	$10.98 -1.7%	$12.13	$9.38 ▼ $15.93	$5.98B	1.03	13.44 million shs	7.30 million shs

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
IRTC iRhythm Technologies	+0.37%	-2.36%	+16.35%	+13.33%	+127.50%
ISRG Intuitive Surgical	-0.43%	+0.21%	-7.60%	-12.41%	-0.61%
PATH UiPath	-1.58%	+4.61%	-12.48%	-9.86%	-9.67%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
IRTC iRhythm Technologies	1.3312 of 5 stars	2.5	1.0	0.0	3.1	0.8	0.6
ISRG Intuitive Surgical	4.7166 of 5 stars	3.3	3.0	4.0	4.1	2.5	1.9
PATH UiPath	3.6597 of 5 stars	4.0	3.0	0.0	2.1	4.2	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
IRTC iRhythm Technologies	3.00	Buy	$157.30	-0.77% Downside
ISRG Intuitive Surgical	2.63	Moderate Buy	$595.95	24.36% Upside
PATH UiPath	2.00	Hold	$13.83	25.94% Upside

Current Analyst Ratings Breakdown

Latest ISRG, IRTC, and PATH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/19/2025	ISRG Intuitive Surgical	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$615.00
8/8/2025	PATH UiPath	Zacks Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
8/1/2025	IRTC iRhythm Technologies	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/1/2025	IRTC iRhythm Technologies	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$145.00 ➝ $190.00
8/1/2025	IRTC iRhythm Technologies	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$139.00 ➝ $170.00
8/1/2025	IRTC iRhythm Technologies	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$130.00 ➝ $180.00
8/1/2025	IRTC iRhythm Technologies	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$151.00 ➝ $180.00
7/23/2025	ISRG Intuitive Surgical	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$547.00 ➝ $585.00
7/23/2025	ISRG Intuitive Surgical	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$575.00 ➝ $595.00
7/23/2025	ISRG Intuitive Surgical	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$590.00 ➝ $600.00
7/23/2025	ISRG Intuitive Surgical	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$559.00 ➝ $599.00

(Data available from 8/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
IRTC iRhythm Technologies	$591.84M	8.61	N/A	N/A	$3.23 per share	49.08
ISRG Intuitive Surgical	$9.15B	18.78	$7.95 per share	60.25	$50.08 per share	9.57
PATH UiPath	$1.43B	4.11	$0.03 per share	368.24	$3.33 per share	3.30

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
IRTC iRhythm Technologies	-$113.29M	-$2.93	N/A	N/A	N/A	-14.06%	-90.03%	-8.52%	10/29/2025 (Estimated)
ISRG Intuitive Surgical	$2.32B	$7.17	66.83	62.80	5.04	28.51%	14.56%	12.93%	10/16/2025 (Estimated)
PATH UiPath	-$73.69M	-$0.12	N/A	N/A	14.63	-4.65%	-3.05%	-1.99%	9/4/2025 (Estimated)

Latest ISRG, IRTC, and PATH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/4/2025	Q2 2026	PATH UiPath	$0.08	N/A	N/A	N/A	$347.36 million	N/A
7/31/2025	Q2 2025	IRTC iRhythm Technologies	-$0.53	-$0.32	+$0.21	-$0.44	$173.94 million	$186.69 million
7/22/2025	Q2 2025	ISRG Intuitive Surgical	$1.93	$2.19	+$0.26	$1.81	$2.35 billion	$2.44 billion
5/29/2025	Q1 2026	PATH UiPath	$0.10	$0.11	+$0.01	-$0.04	$332.17 million	$356.62 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
IRTC iRhythm Technologies	N/A	N/A	N/A	N/A	N/A
ISRG Intuitive Surgical	N/A	N/A	N/A	N/A	N/A
PATH UiPath	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
IRTC iRhythm Technologies	6.25	5.02	4.88
ISRG Intuitive Surgical	N/A	5.17	4.18
PATH UiPath	N/A	2.95	2.95

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
IRTC iRhythm Technologies	N/A
ISRG Intuitive Surgical	83.64%
PATH UiPath	62.50%

Insider Ownership

Company	Insider Ownership
IRTC iRhythm Technologies	0.68%
ISRG Intuitive Surgical	0.70%
PATH UiPath	23.19%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
IRTC iRhythm Technologies	2,000	32.13 million	31.91 million	Optionable
ISRG Intuitive Surgical	15,638	358.48 million	355.97 million	Optionable
PATH UiPath	3,868	535.04 million	410.96 million	Optionable

ISRG, IRTC, and PATH Headlines

Recent News About These Companies

Agentic RPA: Transforming Enterprise Automation Through Autonomous Decision-Making

August 19 at 5:54 PM | analyticsinsight.netA

UiPath Stock Falls 11% in 3 Months: Should You Buy the Dip or Wait?

August 19 at 12:56 PM | zacks.com

2 of Wall Street’s Favorite Stocks for Long-Term Investors and 1 Facing Challenges

August 19 at 12:53 PM | msn.com

Not just faster, but smarter and with reasoning: How agentic AI can help firms achieve more

August 19 at 7:52 AM | straitstimes.comS

UiPath, Inc. (NYSE:PATH) Shares Sold by Vestmark Advisory Solutions Inc.

August 19 at 5:18 AM | marketbeat.com

Russell Investments Group Ltd. Has $14.08 Million Stake in UiPath, Inc. $PATH

August 19 at 4:54 AM | marketbeat.com

UiPath (PATH) Launches Generative Extractions to Automate Complex Document Processing

August 18 at 5:18 AM | msn.com

Most ASEAN organizations adopting AI agents in the next 12 months

August 17 at 4:20 AM | msn.com

UiPath, Inc. (NYSE:PATH) Shares Purchased by Deutsche Bank AG

August 16, 2025 | marketbeat.com

Vanguard Group Inc. Grows Stake in UiPath, Inc. (NYSE:PATH)

August 16, 2025 | marketbeat.com

Automation Boom Fuels PATH's Performance in Growing RPA Market

August 15, 2025 | zacks.com

Neuberger Berman Group LLC Trims Position in UiPath, Inc. (NYSE:PATH)

August 15, 2025 | marketbeat.com

Entropy Technologies LP Reduces Holdings in UiPath, Inc. (NYSE:PATH)

August 15, 2025 | marketbeat.com

Mitsubishi UFJ Asset Management Co. Ltd. Increases Holdings in UiPath, Inc. (NYSE:PATH)

August 15, 2025 | marketbeat.com

UiPath (PATH) Stock Drops Despite Market Gains: Important Facts to Note

August 14, 2025 | zacks.com

Humans in control, AI at work: Building agents that deliver real business value

August 14, 2025 | businesstimes.com.sgB

IDC: Agentic AI seen as path to scalable AI in Australia

August 14, 2025 | arnnet.com.auA

How specialized AI agents unlock accurate enterprise automation

August 14, 2025 | diginomica.comD

Near 52-Week Low, Should You Buy UiPath Stock?

August 14, 2025 | fool.com

Traders Purchase High Volume of Put Options on UiPath (NYSE:PATH)

August 13, 2025 | americanbankingnews.com

UiPath Sees Unusually Large Options Volume (NYSE:PATH)

August 12, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

ISRG, IRTC, and PATH Company Descriptions

iRhythm Technologies NASDAQ:IRTC

$158.52 +0.59 (+0.37%)

Closing price 08/19/2025 04:00 PM Eastern

Extended Trading

$158.36 -0.16 (-0.10%)

As of 07:52 AM Eastern

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Intuitive Surgical NASDAQ:ISRG

$479.20 -2.08 (-0.43%)

Closing price 08/19/2025 04:00 PM Eastern

Extended Trading

$480.10 +0.90 (+0.19%)

As of 07:53 AM Eastern

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

UiPath NYSE:PATH

$10.98 -0.19 (-1.67%)

Closing price 08/19/2025 03:59 PM Eastern

Extended Trading

$10.94 -0.04 (-0.36%)

As of 07:53 AM Eastern

UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric. It serves banking and financial services, healthcare, insurance, public sectors, manufacturing, retail, and telecom industries. The company was founded in 2005 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time